Canada makes pledge of CAD 675 million in new funding for Gavi, the Vaccine Alliance’s next strategic period from 2026 to 2030
The support moves Gavi closer to its goal to immunise at least 500 million children and keep our world safe by investing in global health security
Hon. Ahmed Hussen, Minister of International Development, Canada: “Gavi is a first-in-class, longstanding global health partner for Canada. Today’s announcement will support critical immunization efforts to protect children and vulnerable populations from life-threatening diseases. Canada is investing in Gavi to reduce the global spread of disease and help children everywhere stay healthy.”
Geneva, 7 March 2025 – Canada has announced a pledge of CAD 675 million in new funding for Gavi, the Vaccine Alliance’s next strategic period from 2026 to 2030, “Gavi 6.0”. The pledge will support Gavi’s aim to protect more people, against more diseases, faster than ever before in its next strategic period.
“Gavi is a first-in-class, longstanding global health partner for Canada. Today’s announcement will support critical immunization efforts to protect children and vulnerable populations from life-threatening diseases. Canada is investing in Gavi to reduce the global spread of disease and help children everywhere stay healthy,” said Hon. Ahmed Hussen, Minister of International Development, Canada.
Canada is a leading donor to Gavi, having provided more than US$1 billion in direct contributions to Gavi since 2002. Canada has also played a critical role in supporting some of Gavi’s most innovative programmes – as a founding donor to the Pneumococcal Conjugate Vaccine Advance Market Commitment (PCV AMC), an innovative pilot financing instrument that has helped increase the availability of suitable and affordable vaccines against pneumonia, and a lead donor to Gavi’s INFUSE programme, which focuses on piloting and scaling up private sector innovations to improve vaccine delivery. Additionally, Canada was a leading donor to Gavi and partners’ efforts to deliver nearly 2 billion COVID-19 vaccines to 146 countries through COVAX – contributing more than US$ 600 million to the efforts, including support for Gavi to set up means to coordinate and deliver donated COVID-19 vaccine doses between countries.
“Today, we are deeply grateful to Canada, and to Canadians, for their commitment to Gavi’s next 5-year strategic period,” said Dr Sania Nishtar, CEO of Gavi. “This vital support builds on many years of partnership, and as we look forward this investment will ensure that hard-won gains are preserved, our outbreak and emergency response mechanisms are leveraged to keep the world safe, the most impactful vaccines continue to be accessible around the world, and that vulnerable populations, particularly women and girls, are given the opportunity to thrive.”
Since 2000, Gavi has protected more than 1.1 billion children against a range of diseases, averting nearly 19 million deaths and helping halve childhood mortality in the countries it supports. The Alliance now needs at least US$ 9 billion for Gavi 6.0, with an aim to help immunise at least 500 million children and save 8-9 million lives from 2026 to 2030. A successful replenishment for Gavi will also help Gavi make its largest ever investment in global health security, expanding its global vaccine stockpiles and support for emergency response. In the next strategic period, Gavi will work with supported countries – who fund more than 40% of the cost of their routine vaccines through the Alliance’s co-financing model – to expand access to critical vaccines. This includes reaching 120 million girls with the HPV vaccine, protecting them against cervical cancer and saving 1.5 million lives, and at least 50 million children with vaccines against malaria. During this time, Gavi’s immunisation programmes are expected to generate more than US$ 100 billion in economic benefits for partner countries.
MEDIA CONTACTS
Meg Sharafudeen
+41 79 711 55 54
msharafudeen@gavi.org
Eunice Kilonzo-Muraya
+41 76 424 85 03
ekilonzo@gavi.org